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As evidence of systemic neutrophil activation, an increased surface CD11 b
expression and a shedding of LECAM·1 on circulating neutrophils was found
in unstable angina compared to stable angina (mean fluorescence CD11 b:
115.6 ± 10.3 vs. 74.0 ± 6.3, p = 0.002, mean fluorescence LECAM-l : 49.8 ±
6.0 vs. 72.1 ± 4.0, P = 0.06), which could be related to the extent of platelet-
neutrophil interaction (CD11b: r = 0.5, p = 0.0005; LECAM-1: r = 0.42, P =
0.012). In vitro studies revealed that binding of purified platelet membranes
to separated neutrophils caused a dose dependent increase in CDll b sur-
face expression and shedding of surface LECAM-1 . Thus, the study demon-
strates that the increased interaction between platelets and leukocytes con-
tributes to the leukocyte activation in unstable angina.
IIka Ott, Franz-Josef Neumann, Meinrad Gawaz, Albert Schbmlg. 1. Medizinische
Klinik, Technische Universitat Munchen, Germany
Experimental studies show an increased interaction between endothelial
cells, leukocytes and platelets in ischemia, which is associated with a release
of mediators that cause microvascular damage. Aim of the study was to in-
vestigate the platelet-leukocyte interaction in patients with unstable angina
and its effect on neutrophil function. Systemic venous blood samples were
taken from 20 patients with stable and from 20 patients with unstable angina
pectoris, as well as from 20 healthy controls. After incubation with FITC-
labelled mAbGPllb-lIla mean cellular fluorescence of neutrophils (PMNI and
monocytes (Mo), identified by CD45 or CD14 binding, was analysed by flow
cytometry Patients with unstable angina showed a significant increase in
platelet-neutrophil and platelet-monocytes conjugates.
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Absence of Ischemia on Ambulatory ECG
Monitoring During Treatment as a Predictor of
Outcome: A Report from the ACIP Study
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Conclusion: Decreased HRV precedes ischemia and suggests the possi-
bility of vagal withdrawal as a trigger of daily lile ischemia.
fore, we analyzed 68 asymptomatic ambulatory ischemic events (> 1 mm
downsloping ST depression, for >60 sec) in 19 men with documented coro-
nary disease during 48 h Holter monitoring. HRV was examined using spec-
tral analysis distinguishing low frequency (If = 0.04-0.15 Hz) and high fre-
quency (hf = 0.15-0.40 Hz) HRV at 60-, 20-, 10-,4-, and 2-minutes prior to,
and 2-, 10-,20-, and 60-minutes after ischemia. To control for heart rate, HRV
was also assessed at similar heart rates during non-ischemic periods. A sig-
nificant (p < 0.05) decrease in hf-HRV was observed in the 10-60 min periods
prior to ischemia and a further drop emerged at both 4- and 2-min prior to
ischemia. In addition, hl-HRV was significantly lower 10- and 4-min priorto is-
chemia (4.26 ± 0.13 and 4.22 ± 0.15) than in the heart rate controlled periods
(4.96 ± 0.29 and 4.93 ± 0.26). Results for If-HRV were similar.
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Triggers of daily life ischemia remain undefined. Evidence suggests that va-
gal withdrawal may produce ischemia by coronary vasoconstriction. Heart
rate variability (HRV) has been shown to be an indicator of vagal tOne. There-
The circadian rhythm of myocardial ischemia is well-established, with a peak
occurring between 6 a.m. and noon. This circadian rhythm has been related
to diurnal variations in exogenous triggers of ischemia (physical and mental
activities). To determine if an underlying endogenous circadian vulnerabil-
ity for ischemia exists independently of the 24-hour changes in exogenous
triggers, we analyzed data of 63 patients (mean age 62 ± 8 years) with docu-
mented coronary artery disease with >24 hr Holter monitoring for ischemia
(~1 mm horizontal or downsloping ST depression, or ~1.5 mm upsloping,
lor <1 min). A validated structured diary system was used to assess physical
and mental activities throughout the day. To assess the endogenous compo-
nent, diurnal fluctuations 01 ischemia were analyzed while statistically con-
trolling for concomitant changes in physical and mental activity using residu-
alized regression scores. The morning increase in ischemia co-occurred with
increases in both physical and mental activity. During the morning, 77% of
the ischemic periods occurred at high physical activity, while activity was
high in 48% of the non-ischemic morning-observations (p < 0.05). For men-
tal activity these percentages were 45% and 29% (p < 0.05). Exogenous
factors affected onset of ischemia to a lesser extent in the afternoon and
Carl J. Pepine, Bernard R. Chaitman, Craig Pratt, Martial G. Bourassa, Peter
H. Stone, Genell L. Knatterud, Sandra Forman, George Sopko, C. Richard Conti,
ACIP Study Group. University of Florida, Gainesville, FL
The presence of ischemia on ambulatory ECG (AECG) monitoring adversely
influences the outcome in patients with coronary artery disease. In the
Asymptomatic Cardiac Ischemia Pilot (ACIP), 618 clinically stable patients
with revascularizable coronary artery disease, abnormal stress tests and
asymptomatic ischemia on AECG monitoring were randomized to 1 of 3
treatment strategies: angina-guided care, ischemia-guided care or revascu-
larization. RepeatAECG monitoring was done at 12 weeks On treatment and
the patients were followed for outcome analysis at 1 year.
At 1 year death, MI or hospitalization occurred in 38 of 262 patients with-
out AECG ischemia at 12 weeks (14.5%), and 55 of 272 (20.2%) 01 those
with AECG ischemia at 12 weeks (p < 0.08). Aggregate adverse outcomes
(death, MI, hospitalization or ischemia on 1 year En) occurred in 160 (61%)
of patients without AECG ischemia at 12 weeks and 225 (83%1 of patients
with AECG ischemia at 12 weeks (p < 0.001).
These data provide evidence to support the hypothesis that AECG moni·
toring results during treatment may be predictive of future coronary events.
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Recent research suggests that inflammatory indexes are increased in unsta-
ble angina; however it is not known if they reflect inflammatory activity in the
coronary arteries or the effects of recurrent ischemia On the myocardium. To
address this issue, in 20 pts with unstable angina (defined as recurrent chest
pain at rest associated with transient ST-T changes) blood samples were si-
multaneously taken from the coronary sinus (CS), from aorta (Ao) and from
the coronary artery (CA) just distally to the culprit lesion. Surface expres-
sion of neutrophils (PMN) and monocytes (MONO) CDll B/CD18 adhesion
receptors was detected by direct immunofluorescence evaluated by flow
cytofluorimetry using monoclonal antibodies tagged with fluorescent mark-
ers. Results are given as molecular equivalents of soluble fluorescein.
'p < 0.02 CS vs Ao, tp < 0.0.2 CS vs CA, &p < 0.02 CS vs AO
These data show that in patients with unstable angina a significant upreg-
ulation of CD11 B/CD18 adhesion receptors of neutrophils and monocytes
occurs in the coronary sinus as compared to the aorta and the culprit lesion
site suggesting that leukocyte activation takes place at the microcirculatory
level and not within the epicardial coronary arteries.
Decreased Heart Rate Variability Precedes Daily
Life Ischemia
Ralph J. Verdino, John S. Gottdiener, Willem J. Kop, Shaun T. O'Leary, Robert
H. Howell, David S. Krantz. Georgetown University Medical Center, Washington, DC
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Long-term Prognostic Significance of Treadmill
Ischemia in "Low-risk" Patients with Coronary
Artery Disease
David Mulcahy, Asi! Rehman, Syed S. Husain, Neil P. Andrews, Gloria Zalos,
William H. Schenke. Arshed A. Ouyyumi. NHLBI, Bethesda, MD
was performed at 4 weeks, LV end-diastolic (EDVI) volume (mllm2), Lown-
grade and OT-duration, corrected for heart rate (OTc, ms) were measured at
4 days, 4 weeks, 0.5,1.5, and 3 years by gated SPECT, Holter and 12-channel
ECG, respectively. During an average follow-up of 59.7 months, 16 patients
died (mortality 12.2%, median survival time of 30 months). Death was pro-
ceeded by progressive LV dilation (left figure) and occurred suddenly in 14
of 16 patients (88%). Extend and severity of ventricular arrhythmias, as indi-
cated by a rise of Lawn-grade from 2.8 ± 0.5 to 3.6 ± 0.5, 5.0 ± 0.4, 5.4 ±
0.3 and 5.8 ± 0.2 at 4 days, 4 weeks, 6 months, 1.5 and 3 years, respectively
(p < 0.00001), increased before death. This was associated with a rise of
OTc from 457 ± 6 at 4 days to 480 ± 9 before death (p = 0,01). In contrast,
EDVI (left Figure) and Lown-grade did not rise and OTc even decreased (457
± 8, 456 ± 8, 424 ± 4, 414 ± 5, 399 ± 4) in survivors (p < 0.05). Extend of
LV dilatation correlated with severity of ventricular arrhythmias (right Figure).
Non-survivors did not differ in drug therapy, electrolytes or initial coronary
status and exercise tests were negative. These findings indicate that pro-
gressive LV dilatation (remodeling I may provide a proarrhythmic substrate
for sudden death after Mi, which deserves more detailed analysis.
Patients with stable single or 2-vessel coronary artery disease (CAD) and nor-
mal, or mildly depressed left ventricular function have a good prognosis. We
have investigated the long-term prognostic significance of a positive exercise
test (ExTestl in this population to establish whether it is useful in identifying
a "high-risk" subgroup within a recognised "low-risk" population. Between
1987-94,162 patients with documented single (n = 89) or double (n = 73)
vessel CAD (exclUding left main and proximal left anterior descending CAD),
left ventricular ejection fraction >35% (mean 51 %, range 36-72%) on ra-
dionuclide ventriculography, and an interpretable ExTest were assigned to
receive medical therapy. There were 123 males and 39 females (mean age
60 yrs). A positive ExTest for ischemia was present in 104 (64%) pts. Pts
were followed for a mean period of 49 months (range 6-82 months), during
which time 34 (21 %) had cardiac events (cardiac death n = 3, myocardial
infarction (AMI) n = 14, unstable angina n = 6, elective revascularisation n =
11). Similar proportion of pts with a positive ExTest and a negative ExTest suf-
fered cardiac events (all events, including revascularization) during follow-up
(21 % and 20.7% respectively). Kaplan Meier survival analysis demonstrated
no difference between the groups. Survival analysis also failed to demon-
strate any difference in the incidence of acute cardiac events (cardiac death
and AMI) between positive and negative ExTest groups; of 15 events, 6 (40%)
occurred in those with a positive Extest. Pts with 2-vessel disease suffered
significantly more events than those with I-vessel disease (29% vs 14.6%, P
< 0.05), but there was no difference in acute events (cardiac death and AMI)
between the two subsets. Even in pts with 2-vessel disease, there was no
difference in survival in those with and without a positive ExTest. The data
indicate that although detection of ischemia by exercise testing is useful as
an initial diagnostic tool, once the coronary anatomy and left ventricular func-
tion are known, the presence of ischemia on treadmill exercise is of limited
prognostic value in "low-risk" pts with stable CAD. These findings are consis-
tent with reports demonstrating that acute cardiac events often result from
plaque rupture in non-significantly stenosed vessels.
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Inadequate Pre-Hospital Medical Therapy in
Patients Undergoing Percutaneous Coronary
Revascularization: Results from the CAVEAT Trial
Mark J. Eisenberg, Louise Pilote, Gordon Keeler, Robert M. Califf, Eric J. Topol,
CAVEAT investigators. Cleveland Clinic Foundation, Cleveland, OH
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Suspected Ischemic Chest Pain: Accuracy and
Cost Efficiency of Emergency Department-based
Evaluation
Ester LeVin, Maureen Lowery, Richard B. Furlong, Robert J. Myerburg. University of
Miami; MiamI; FL
Hospital admissions to exclude myocardial ischemia as one possible cause
of unexplained chest pain (CP) are costly and have a low positive diagnostic
yield. This prospective study was performed to determine whether a compre-
hensive emergency department (ED I-based cardiology service provides ac-
curate diagnoses with a significant cost savings. A special cardiology service
providing consultations, exercise testing and echocardiography was used to
evaluate 97 consecutive emergency department patients (pts) (44 male, 53
female) who presented with CP The pts had one or more risk factors for coro-
nary artery disease, a suspicious but atypical CP pattern, and no ECG/enzyme
evidence of acute myocardial injury. To qualify, each pt had to be considered
an appropriate candidate for hospital admission to evaluate CP by the ED
physician. Based on negative exercise testing results performed upon clin-
ical evaluation in the ED, all pts were discharged to continued non-cardiac
ambulatory work-up. Mean cost of the evaluation was $1683 ± $871. A con-
trol group of 36 pts with similar symptoms underwent identical diagnostic
procedures on an in-patient basis. In all cases, myocardial ischemia origin of
the CP was excluded and the pts were discharged to various out-patient ser-
vices. The mean cost of their hospital stay was $6358 ± $1884. We conclude
that comprehensive cardiology service within an emergency department is
a reliable alternative to hospitalization and results in a 74% cost-reduction
for evaluation of a pt with atypical chest pain.
evening. After correcting ischemic time for each patient's simultaneously
measured activity level, a significant circadian fluctuation of ischemic time
was still observed (p < 0.001) with an early morning peak at 6 a.m.
Conclusion: There is an underlying endogenous circadian rhythm of is-
chemic vulnerability, which is independent of exogenous factors. Exogenous
factors are most potent as triggers of ischemia at the time of morning peak
of the endogenous variation in vulnerability for ischemia.
Background: Patients with known coronary artery disease rnay be receiv-
ing inadequate medical therapy prior to referral for percutaneous coronary
revascularization. Methods: To examine the medical treatment of patients re-
ferred for percutaneous coronary revascularization, we analyzed pre-hospital
treatment data and concomitant medical conditions from the CAVEAT I trial.
Results: Of the 1,012 patients referred for revascularization 68.3% had unsta-
ble angina, 17.6% had stable angina, 9.8% had chest pain after myocardial
infarction, and 4.3% were asymptomatic with a positive functional study.
Prior to PTCA or directional atherectomy (DCA), patients had low rates of
treatment with aspirin, nitrates, calcium channel blockers, beta-blockers, and
anti-lipid agents (Table). Pre-hospital medications were associated with the
following conditions: aspirin-none, nitrates-none, calcium channel blockers-
hypertension (p = 0.004) and absence of unstable angina (p = 0.046), beta
blockers-hypertension (p = 0.01), and anti-lipid agentS-hyperlipidemia Ip =
0.0001) and number of diseased vessels (p = 0035). Conclusions: These
data strongly indicate that patients referred for percutaneous coronary revas-
cularization have inadequate pre-hospital medical treatment.
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Peter Gaudron, Ingrid Kugler, Kai Hu, Christoph Eilles 1, Maximilian Scheubeck,
Georg Ertl. University of Wurzburg, Germany: 1Regensburg. Germany
Although left ventricular (LV) dilation after myocardial infarction (Mi) carries
an adverse prognosis, it is unclear whether individual patients indeed die
with progressive remodeling, and how dilation is related to death.
We assessed 131 consecutive asymptomatic patients during 5 years after
uncomplicated first myocardial infarction (Mi). In each, coronary angiography
Nina Rehnqvist. Paul Hjemdahl 1, Ewa Billing, Inge Bjorkander, Sven V Eriksson,
Lennart Forslund, Claes Held, Per Nasman, N. Hakan Wallen 1. Karolinska Instituter.
Department of Internal Medicine, Danderyd Hospital, Danderyd, Sweden; 1 Department
of Clinical Pharmacology- Karolinska Hospital- Stockholm, Sweden
The effect of treatment with metoprolol or verapamil was investigated in 809
patients with stable angina pectoris. End points for the study were: death,
!990-51 I Mechanisms and Predictors of Late Death in
Asymptomatic Patients After Myocardial
Infarction. A Prospective Study on Remodeling
1990-53 1 Effects on Cardiovascular End Points and
Psychological Variables of Metoprolol and
Verapamil in Patients with Stable Angina Pectoris
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